No Data
No Data
SSY Group's Muscle Relaxant Drug Secures China Approval
ssy group (02005.HK): Benzene Sulfonate Bupropion Approved for Registration as an active pharmaceutical ingredient for use in listed preparations
SSY Group (02005.HK) announced on October 14 that its Succinylcholine Benzene has been approved by the China National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations. Succinylcholine Benzene is a muscle relaxant used primarily for muscle tension, sedation, general anesthesia during tracheal intubation, and as an adjunct in general anesthesia.
Express News | SSY Group - Cisatracurium Besilate Obtained Approval for Registration From National Medical Products Administration
SSY Group Limited's (HKG:2005) Last Week's 4.5% Decline Must Have Disappointed Private Companies Who Have a Significant Stake
ssy group (02005.HK) cancelled 7.314 million shares for repurchase on September 27th.
Gelonghui September 27th | ssy Group (02005.HK) announced that a total of 7.314 million shares will be cancelled for repurchase on September 27, 2024.
China Tong Hong Kong shareholder equity disclosure | September 26th
Hong Kong shareholders' equity disclosure | September 26th
No Data
No Data